GALWAY, IRELAND--June 17, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--GlaxoSmithKline (NYSE:GSK) (GSK) (Brentford, England) has agreed to sell its pharmaceutical manufacturing plant in Cork, Ireland, to U.S. company Thermo Fisher Scientific Incorporated (NYSE:TMO) (Waltham, Massachusetts) for 90 million euro ($102 million). Within this article: Details plant sale, products produced, future plans and related GSK plant sell offs
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
